Pharmaceutical Secretary Manj Joshi noted that the significant profitability of medicines is causing concern because it can influence product selection or facilitate improper actions.
In this regard, the government is strengthening control over unscrupulous participants in the healthcare sector, including hospitals and pharmaceutical companies.